Clinical and social determinants of psychotropic drug prescription for schizophrenia outpatients in China

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 31, Issue 3, 2007, Pages 756-760

  Xiang, Yu Tao ^a,b   Weng, Yong Zhen ^b   Leung, Chi Ming ^a   Tang, Wai Kwong ^a   Ungvari, Gabor Sandor ^a   Gerevich, Jozsef ^c  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c EÖTVÖS LORÁND UNIVERSITY   (Hungary)

Author keywords

China; Outpatients; Prescription patterns; Schizophrenia

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CHLORPROMAZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE; MOOD STABILIZER; PSYCHOTROPIC AGENT;

ADULT; AGE DISTRIBUTION; ANXIETY; ARTICLE; CHINA; DEMOGRAPHY; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE POLICY; HONG KONG; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; POLYPHARMACY; PREDICTION; PRESCRIPTION; QUALITY OF LIFE; SCHIZOPHRENIA; SOCIAL ASPECT; SYMPTOM;

ADOLESCENT; ADULT; CHINA; DEMOGRAPHY; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; OUTPATIENTS; PRESCRIPTIONS, DRUG; PSYCHOTROPIC DRUGS; QUALITY OF LIFE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; SOCIAL CONDITIONS; STATISTICS, NONPARAMETRIC;

EID: 33947533978     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2007.01.013     Document Type: Article

References (23)

1. APA. Diagnostic and statistical manual of mental disorders. 4th ed (1994), American Psychiatric Association, Washington
2. Barnes T.R. A rating scale for drug-induced akathisia. Br J Psychiatry 154 (1989) 672-676
3. Barnes T.R., and Curson D.A. Long-term depot antipsychotics. A risk-benefit assessment. Drug Safety 10 (1994) 464-479
4. Binder R.L., Kazamatsuri H., Nishimura T., and McNiel D.E. Tardive dyskinesia and neuroleptic-induced parkinsonism in Japan. Am J Psychiatry 144 (1987) 1494-1496
5. Carnahan R.M., Lund B.C., Perry P.J., and Chrischilles E.A. Increased risk of extrapyramidal side-effect treatment associated with atypical antipsychotic polytherapy. Acta Psychiatr Scand 113 (2006) 135-141
6. Gerlach J. Depot neuroleptics in relapse prevention: advantages and disadvantages. Int Clin Psychopharmacol 9 Suppl 5 (1995) 17-20
7. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 23 (1960) 56-62
8. Humberstone V., Wheeler A., and Lambert T. An audit of outpatient antipsychotic usage in the three health sectors of Auckland, New Zealand. Aust N Z J Psychiatry 38 (2004) 240-245
9. Kane J.M. Schizophrenia. N Engl J Med 334 (1996) 34-41
10. Lobana A., Mattoo S.K., Basu D., and Gupta N. Quality of life in schizophrenia in India: comparison of three approaches. Acta Psychiatr Scand 104 (2001) 51-55
11. Overall J.E., and Beller S.A. The Brief Psychiatric Rating Scale (BPRS) in geropsychiatric research: I. Factor structure on an inpatient unit. J Gerontol 39 (1984) 187-193
12. Phillips M.R., Lu S.H., and Wang R.W. Economic reforms and the acute inpatient care of patients with schizophrenia: the Chinese experience. Am J Psychiatry 154 (1997) 1228-1234
13. Remington G., Saha A., Chong S.A., and Shammi C. Augmentation strategies in clozapine-resistant schizophrenia. CNS Drugs 19 (2005) 843-872
14. Schuklenk U. Helsinki Declaration revisions. Issues Med Ethics 9 (2001) 29
15. Sim K., Su A., Chan Y.H., Shinfuku N., Kua E.H., and Tan C.H. Clinical correlates of antipsychotic polytherapy in patients with schizophrenia in Singapore. Psychiatry Clin Neurosci 58 (2004) 324-329
16. Sim K., Su A., Fujii S., Yang S.Y., Chong M.Y., Ungvari G.S., et al. Antipsychotic polypharmacy in patients with schizophrenia: a multicentre comparative study in East Asia. Br J Clin Pharmacol 58 (2004) 178-183
17. Sim K., Su A., Leong J.Y., Yip K., Chong M.Y., Fujii S., et al. High dose antipsychotic use in schizophrenia: findings of the REAP (research on East Asia psychotropic prescriptions) study. Pharmacopsychiatry 37 (2004) 175-179
18. Sim K., Su A., Ungvari G.S., Fujii S., Yang S.Y., Chong M.Y., et al. Depot antipsychotic use in schizophrenia: an East Asian perspective. Hum Psychopharmacol 19 (2004) 103-109
19. Simpson G.M., and Angus J.W. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl 212 (1970) 11-19
20. Taylor D., Paton C., and Kerwin R. The Maudsley prescribing guidelines (2003), Martin Dunitz, London
21. Ungvari G.S., Chow L.Y., Chiu H.F., Ng F.S., and Leung T. Modifying psychotropic drug prescription patterns: a follow-up survey. Psychiatry Clin Neurosci 51 (1997) 309-314
22. Ungvari G.S., Chung Y.G., Chee Y.K., Fung-Shing N., Kwong T.W., and Chiu H.F. The pharmacological treatment of schizophrenia in Chinese patients: a comparison of prescription patterns between 1996 and 1999. Br J Clin Pharmacol 54 (2002) 437-444
23. Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group. Psychol Med 28 (1998) 551-558